Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W F Wilson

Showing results (61-70 of 391) with videos related to

Pageof 40
Sort By:
The American Journal of Cardiology|October 3, 2002
Risk stratification of obesity as a coronary risk factorWilliam B Kannel, Peter W F Wilson, Byung-Ho Nam, et al.
Journal of the Cardiometabolic Syndrome|November 6, 2008
Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factorsPeter W F Wilson, Henry R Black, Anthony N Fabricatore, et al.
Diabetes & Vascular Disease Research|October 30, 2008
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end pointsAbhinav Goyal, Kara Nerenberg, Hertzel C Gerstein, et al.
Archives of Internal Medicine|August 28, 2002
Overweight and obesity as determinants of cardiovascular risk: the Framingham experiencePeter W F Wilson, Ralph B D'Agostino, Lisa Sullivan, et al.
Circulation|April 2, 2019
Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?Cecilia C Low Wang, Brendan M Everett, Kenneth D Burman, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
Heritability of age at natural menopause in the Framingham Heart StudyJoanne M Murabito, Qiong Yang, Caroline Fox, et al.
Circulation|November 9, 2005
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitusPeter W F Wilson, Ralph B D'Agostino, Helen Parise, et al.
Journal of the American Heart Association|July 5, 2022
Highlights in ASCVD Primary Prevention for 2021Tamar S Polonsky, Amit Khera, Michael D Miedema, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart StudyPeter W F Wilson, Michael Pencina, Paul Jacques, et al.
Ophthalmology|March 8, 2003
Serum lipids and age-related lens opacities: a longitudinal investigation: the Framingham StudiesRita Hiller, Robert D Sperduto, George F Reed, et al.
Pageof 40

Showing results (61-70 of 391) with videos related to

Sort By:
Pageof 40
The American Journal of Cardiology|October 3, 2002
Risk stratification of obesity as a coronary risk factorWilliam B Kannel, Peter W F Wilson, Byung-Ho Nam, et al.
Journal of the Cardiometabolic Syndrome|November 6, 2008
Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factorsPeter W F Wilson, Henry R Black, Anthony N Fabricatore, et al.
Diabetes & Vascular Disease Research|October 30, 2008
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end pointsAbhinav Goyal, Kara Nerenberg, Hertzel C Gerstein, et al.
Archives of Internal Medicine|August 28, 2002
Overweight and obesity as determinants of cardiovascular risk: the Framingham experiencePeter W F Wilson, Ralph B D'Agostino, Lisa Sullivan, et al.
Circulation|April 2, 2019
Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?Cecilia C Low Wang, Brendan M Everett, Kenneth D Burman, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
Heritability of age at natural menopause in the Framingham Heart StudyJoanne M Murabito, Qiong Yang, Caroline Fox, et al.
Circulation|November 9, 2005
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitusPeter W F Wilson, Ralph B D'Agostino, Helen Parise, et al.
Journal of the American Heart Association|July 5, 2022
Highlights in ASCVD Primary Prevention for 2021Tamar S Polonsky, Amit Khera, Michael D Miedema, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart StudyPeter W F Wilson, Michael Pencina, Paul Jacques, et al.
Ophthalmology|March 8, 2003
Serum lipids and age-related lens opacities: a longitudinal investigation: the Framingham StudiesRita Hiller, Robert D Sperduto, George F Reed, et al.
Pageof 40